Lucía Citores1, Rosario Iglesias1, José M Ferreras1. 1. Department of Biochemistry and Molecular Biology and Physiology, Faculty of Sciences, University of Valladolid, E-47011 Valladolid, Spain.
Abstract
Ribosome-inactivating proteins (RIPs) are rRNA N-glycosylases from plants (EC 3.2.2.22) that inactivate ribosomes thus inhibiting protein synthesis. The antiviral properties of RIPs have been investigated for more than four decades. However, interest in these proteins is rising due to the emergence of infectious diseases caused by new viruses and the difficulty in treating viral infections. On the other hand, there is a growing need to control crop diseases without resorting to the use of phytosanitary products which are very harmful to the environment and in this respect, RIPs have been shown as a promising tool that can be used to obtain transgenic plants resistant to viruses. The way in which RIPs exert their antiviral effect continues to be the subject of intense research and several mechanisms of action have been proposed. The purpose of this review is to examine the research studies that deal with this matter, placing special emphasis on the most recent findings.
Ribosome-inactivating proteins (RIPs) are rRn class="Chemical">NA N-glycosylases from plants (EC 3.2.2.22) that inactivate ribosomes thus inhibiting protein synthesis. The antiviral properties of RIPs have been investigated for more than four decades. However, interest in these proteins is rising due to the emergence of infectious diseases caused by new viruses and the difficulty in treating viral infections. On the other hand, there is a growing need to control crop diseases without resorting to the use of phytosanitary products which are very harmful to the environment and in this respect, RIPs have been shown as a promising tool that can be used to obtain transgenic plants resistant to viruses. The way in which RIPs exert their antiviral effect continues to be the subject of intense research and several mechanisms of action have been proposed. The purpose of this review is to examine the research studies that deal with this matter, placing special emphasis on the most recent findings.
Entities:
Keywords:
adenine polynucleotide glycosylase; antiviral therapy; human virus; immunotoxin; rRNA glycosylase (EC 3.2.2.22); ribosome-inactivating protein (RIP); virus-resistant transgenic plant (VRTP)
Authors: V S Byers; A S Levin; L A Waites; B A Starrett; R A Mayer; J A Clegg; M R Price; R A Robins; M Delaney; R W Baldwin Journal: AIDS Date: 1990-12 Impact factor: 4.177
Authors: Shihyoung Kim; Rajni Kant Shukla; Eunsoo Kim; Sophie G Cressman; Hannah Yu; Alice Baek; Hyewon Choi; Alan Kim; Amit Sharma; Zhirui Wang; Christene A Huang; John C Reneau; Prosper N Boyaka; Namal P M Liyanage; Sanggu Kim Journal: Biomedicines Date: 2022-05-24
Authors: Nicola Landi; Sara Ragucci; Lucía Citores; Angela Clemente; Hafiza Z F Hussain; Rosario Iglesias; José M Ferreras; Antimo Di Maro Journal: Toxins (Basel) Date: 2022-08-19 Impact factor: 5.075
Authors: Leonardo R Ancheta; Patrick A Shramm; Raschel Bouajram; Denise Higgins; Douglas A Lappi Journal: Toxins (Basel) Date: 2022-03-02 Impact factor: 4.546